Hyundai Pharm Donates Medicines to Overseas Medical Volunteer Group 'Soul Love People'
Supporting Underdeveloped Countries Facing Difficulties in Accessing Medicines
Hyundai Pharm announced on the 21st that it has donated pharmaceuticals to 'Soul Love People,' an overseas medical volunteer organization that provides medicines and medical services to marginalized communities.
As a pharmaceutical company, Hyundai Pharm decided to donate medicines to fulfill its social responsibility and contribute to improving the health of people around the world. The donated medicines will be delivered to residents of underdeveloped countries who face difficulties in accessing pharmaceuticals.
Major donated items include 'Jeonwoo Aqua Guard Solution,' a mosquito and tick repellent; 'Metarocin Ointment,' used for wounds and bacterial skin infections; 'Sinoflu Cold,' a cold remedy; 'Spectamin Gold,' a comprehensive nutritional supplement; 'Pompomi' (Hydropatch, high-elasticity bandage), which can be applied to wounds; and 'Urintamin,' used for benign prostatic hyperplasia.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A Hyundai Pharm representative stated, "We hope that the donated medicines will reach those who need them most and provide practical help," adding, "We will continue to engage in various social contribution activities to fulfill our social responsibility in the future."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.